A Study of Tralokinumab When Delivered Subcutaneously at Different Flow Rates to Healthy Volunteers

Summary

The primary objective of this study is to evaluate the pharmacokinetics (PK) and tolerability of tralokinumab when delivered subcutaneously at different flow rates to healthy volunteers.

Timeline

Start

2014-03-19

Primary completion

2014-07-10

Completion

2014-07-10

Publications

• Background Jain M, Doughty D, Clawson C, Li X, White N, Agoram B, van der Merwe R. Tralokinumab pharmacokinetics and tolerability when administered by different subcutaneous injection methods and rates . Int J Clin Pharmacol Ther. 2017 Jul;55(7):606-620. doi: 10.5414/CP203023.

Drugs

Indications